chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 36.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Electrocardiogram, Palpitations, Ultrasound thyroid, Vertigo
Clinical narrative: Fainting like episodes; Blurred vision; Severe vertigo; Chest pain; Fatigue; This is a spontaneous report from a contactable other health professional reported for herself.    A 36-year-old female patient received first dose BNT162B2(PFIZER-BIONTECH COVID-19 VACCINE) Lot # EL8982, via an unspecified route of administration in right arm on 15Jan2021 12:00 at single dose for covid-19 immunisation.  There were no relevant medical history or concomitant medications. The patient was not pregnant at the time of vaccination.The patient had no allergies to medications, food, or other products.The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine.On 21Jan2021, exactly "4 1/2 days" after vaccine the patient experienced fainting like episodes, blurred vision, severe vertigo, chest pain, fatigue. The patient has been out of work since the 20th and she still had blurred vision. The adverse event resulted in Doctor or other healthcare professional office/clinic visit and Emergency room/department or urgent care. No treatment was received. The patient was not recovered from the events. She has been to the ER, cardiologist for an echography, ultrasonography of thyroids, Magnetic resonance imaging (MRI) of her head, went to ENT dr and neurologist in 2021. All blood work in 2021 came back normal as well. The reporter considered the event as non-serious. The patient was not diagnosed with COVID-19 prior to vaccination. She had negative Nasal Swab Covid test post vaccination on 22Jan2021.; Sender's Comments: Considering the temporal association, a causal association between administration of BNT162B2 and the onset of fainting like episodes cannot be fully excluded.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Age: 36.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood test, COVID-19, Chest pain, Fatigue, Magnetic resonance imaging
Clinical narrative: Fainting like episodes; Blurred vision; Severe vertigo; Chest pain; Fatigue; This is a spontaneous report from a contactable other health professional reported for herself.    A 36-year-old female patient received first dose BNT162B2(PFIZER-BIONTECH COVID-19 VACCINE) Lot # EL8982, via an unspecified route of administration in right arm on 15Jan2021 12:00 at single dose for covid-19 immunisation.  There were no relevant medical history or concomitant medications. The patient was not pregnant at the time of vaccination.The patient had no allergies to medications, food, or other products.The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine.On 21Jan2021, exactly "4 1/2 days" after vaccine the patient experienced fainting like episodes, blurred vision, severe vertigo, chest pain, fatigue. The patient has been out of work since the 20th and she still had blurred vision. The adverse event resulted in Doctor or other healthcare professional office/clinic visit and Emergency room/department or urgent care. No treatment was received. The patient was not recovered from the events. She has been to the ER, cardiologist for an echography, ultrasonography of thyroids, Magnetic resonance imaging (MRI) of her head, went to ENT dr and neurologist in 2021. All blood work in 2021 came back normal as well. The reporter considered the event as non-serious. The patient was not diagnosed with COVID-19 prior to vaccination. She had negative Nasal Swab Covid test post vaccination on 22Jan2021.; Sender's Comments: Considering the temporal association, a causal association between administration of BNT162B2 and the onset of fainting like episodes cannot be fully excluded.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Age: 36.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Syncope, Ultrasound scan, Ultrasound thyroid, Vertigo, Vision blurred
Clinical narrative: Fainting like episodes; Blurred vision; Severe vertigo; Chest pain; Fatigue; This is a spontaneous report from a contactable other health professional reported for herself.    A 36-year-old female patient received first dose BNT162B2(PFIZER-BIONTECH COVID-19 VACCINE) Lot # EL8982, via an unspecified route of administration in right arm on 15Jan2021 12:00 at single dose for covid-19 immunisation.  There were no relevant medical history or concomitant medications. The patient was not pregnant at the time of vaccination.The patient had no allergies to medications, food, or other products.The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine.On 21Jan2021, exactly "4 1/2 days" after vaccine the patient experienced fainting like episodes, blurred vision, severe vertigo, chest pain, fatigue. The patient has been out of work since the 20th and she still had blurred vision. The adverse event resulted in Doctor or other healthcare professional office/clinic visit and Emergency room/department or urgent care. No treatment was received. The patient was not recovered from the events. She has been to the ER, cardiologist for an echography, ultrasonography of thyroids, Magnetic resonance imaging (MRI) of her head, went to ENT dr and neurologist in 2021. All blood work in 2021 came back normal as well. The reporter considered the event as non-serious. The patient was not diagnosed with COVID-19 prior to vaccination. She had negative Nasal Swab Covid test post vaccination on 22Jan2021.; Sender's Comments: Considering the temporal association, a causal association between administration of BNT162B2 and the onset of fainting like episodes cannot be fully excluded.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Age: 28.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Asthenia, Chills, Fatigue, Headache
Clinical narrative: tingling and numbness in hands and feet; tingling and numbness in hands and feet; weakness; fatigue; muscle and joint pain; muscle and joint pain; chills; fever of 100.4 F; headache; nausea; This is a spontaneous report from a contactable healthcare professional (patient). A 28-year-old female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL9262 and expiry date unknown), via an unspecified route of administration on 26Jan2021 18:00 at a single dose on the left arm for COVID-19 immunization. Medical history included asthma, fibromyalgia, ADHD, GERD, IBS, and allergies to pollen and yellow onions. Concomitant medications included bupropion hydrochloride (WELLBUTRIN), diltiazem, and topiramate. Patient is not pregnant at the time of vaccination. The patient received the first dose of bnt162b2 on 05Jan2021 15:00 (lot number: EL1284) on the left arm. The patient was not diagnosed with COVID-19 prior to vaccination. Patient was tested for COVID-19 post-vaccination: Tempus iC SARS-CoV-2 RT-PCR on 28Jan2021 with result negative. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 27Jan2021 14:00, within 24 hours after administration of second dose, patient began experiencing tingling and numbness in hands and feet, weakness, fatigue, muscle and joint pain, chills, fever of 100.4 F, headache, and nausea, in that order developing over the next 48 hours. Patient has not recovered from the events. Adverse events resulted in doctor or other healthcare professional office/clinic visit. Treatment received for the adverse events includes Tylenol. Events reported as non-serious.
Age: 28.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Myalgia, Nausea, Paraesthesia, Pyrexia, SARS-CoV-2 test
Clinical narrative: tingling and numbness in hands and feet; tingling and numbness in hands and feet; weakness; fatigue; muscle and joint pain; muscle and joint pain; chills; fever of 100.4 F; headache; nausea; This is a spontaneous report from a contactable healthcare professional (patient). A 28-year-old female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL9262 and expiry date unknown), via an unspecified route of administration on 26Jan2021 18:00 at a single dose on the left arm for COVID-19 immunization. Medical history included asthma, fibromyalgia, ADHD, GERD, IBS, and allergies to pollen and yellow onions. Concomitant medications included bupropion hydrochloride (WELLBUTRIN), diltiazem, and topiramate. Patient is not pregnant at the time of vaccination. The patient received the first dose of bnt162b2 on 05Jan2021 15:00 (lot number: EL1284) on the left arm. The patient was not diagnosed with COVID-19 prior to vaccination. Patient was tested for COVID-19 post-vaccination: Tempus iC SARS-CoV-2 RT-PCR on 28Jan2021 with result negative. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 27Jan2021 14:00, within 24 hours after administration of second dose, patient began experiencing tingling and numbness in hands and feet, weakness, fatigue, muscle and joint pain, chills, fever of 100.4 F, headache, and nausea, in that order developing over the next 48 hours. Patient has not recovered from the events. Adverse events resulted in doctor or other healthcare professional office/clinic visit. Treatment received for the adverse events includes Tylenol. Events reported as non-serious.
Age: 28.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Asthenia, Body temperature, Chills, Fatigue
Clinical narrative: tingling and numbness in hands and feet; tingling and numbness in hands and feet; weakness; fatigue; muscle and joint pain; muscle and joint pain; chills; fever of 100.4 F; headache; nausea; This is a spontaneous report from a contactable healthcare professional (patient). A 28-year-old female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL9262 and expiry date unknown), via an unspecified route of administration on 26Jan2021 18:00 at a single dose on the left arm for COVID-19 immunization. Medical history included asthma, fibromyalgia, ADHD, GERD, IBS, and allergies to pollen and yellow onions. Concomitant medications included bupropion hydrochloride (WELLBUTRIN), diltiazem, and topiramate. Patient is not pregnant at the time of vaccination. The patient received the first dose of bnt162b2 on 05Jan2021 15:00 (lot number: EL1284) on the left arm. The patient was not diagnosed with COVID-19 prior to vaccination. Patient was tested for COVID-19 post-vaccination: Tempus iC SARS-CoV-2 RT-PCR on 28Jan2021 with result negative. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 27Jan2021 14:00, within 24 hours after administration of second dose, patient began experiencing tingling and numbness in hands and feet, weakness, fatigue, muscle and joint pain, chills, fever of 100.4 F, headache, and nausea, in that order developing over the next 48 hours. Patient has not recovered from the events. Adverse events resulted in doctor or other healthcare professional office/clinic visit. Treatment received for the adverse events includes Tylenol. Events reported as non-serious.
Age: 28.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Headache, Hypoaesthesia, Myalgia, Nausea, Paraesthesia
Clinical narrative: tingling and numbness in hands and feet; tingling and numbness in hands and feet; weakness; fatigue; muscle and joint pain; muscle and joint pain; chills; fever of 100.4 F; headache; nausea; This is a spontaneous report from a contactable healthcare professional (patient). A 28-year-old female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL9262 and expiry date unknown), via an unspecified route of administration on 26Jan2021 18:00 at a single dose on the left arm for COVID-19 immunization. Medical history included asthma, fibromyalgia, ADHD, GERD, IBS, and allergies to pollen and yellow onions. Concomitant medications included bupropion hydrochloride (WELLBUTRIN), diltiazem, and topiramate. Patient is not pregnant at the time of vaccination. The patient received the first dose of bnt162b2 on 05Jan2021 15:00 (lot number: EL1284) on the left arm. The patient was not diagnosed with COVID-19 prior to vaccination. Patient was tested for COVID-19 post-vaccination: Tempus iC SARS-CoV-2 RT-PCR on 28Jan2021 with result negative. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 27Jan2021 14:00, within 24 hours after administration of second dose, patient began experiencing tingling and numbness in hands and feet, weakness, fatigue, muscle and joint pain, chills, fever of 100.4 F, headache, and nausea, in that order developing over the next 48 hours. Patient has not recovered from the events. Adverse events resulted in doctor or other healthcare professional office/clinic visit. Treatment received for the adverse events includes Tylenol. Events reported as non-serious.
Age: 28.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pyrexia, SARS-CoV-2 test
Clinical narrative: tingling and numbness in hands and feet; tingling and numbness in hands and feet; weakness; fatigue; muscle and joint pain; muscle and joint pain; chills; fever of 100.4 F; headache; nausea; This is a spontaneous report from a contactable healthcare professional (patient). A 28-year-old female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL9262 and expiry date unknown), via an unspecified route of administration on 26Jan2021 18:00 at a single dose on the left arm for COVID-19 immunization. Medical history included asthma, fibromyalgia, ADHD, GERD, IBS, and allergies to pollen and yellow onions. Concomitant medications included bupropion hydrochloride (WELLBUTRIN), diltiazem, and topiramate. Patient is not pregnant at the time of vaccination. The patient received the first dose of bnt162b2 on 05Jan2021 15:00 (lot number: EL1284) on the left arm. The patient was not diagnosed with COVID-19 prior to vaccination. Patient was tested for COVID-19 post-vaccination: Tempus iC SARS-CoV-2 RT-PCR on 28Jan2021 with result negative. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 27Jan2021 14:00, within 24 hours after administration of second dose, patient began experiencing tingling and numbness in hands and feet, weakness, fatigue, muscle and joint pain, chills, fever of 100.4 F, headache, and nausea, in that order developing over the next 48 hours. Patient has not recovered from the events. Adverse events resulted in doctor or other healthcare professional office/clinic visit. Treatment received for the adverse events includes Tylenol. Events reported as non-serious.
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest X-ray normal, Muscular weakness, Musculoskeletal pain, Pain, Pain in extremity
Clinical narrative: severe right extremity pain, radiating down right arm; with rt arm weakness, numbness and tingling; with rt arm weakness, numbness and tingling; with rt arm weakness, numbness and tingling; brachial plexus neuritis / parsonage turner syndrome; brachial plexus neuritis / parsonage turner syndrome; This is a spontaneous report from a contactable nurse (patient). A 40-year-old female patient (not pregnant) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number=EK5730), via an unspecified route of administration on 18Dec2020 09:30 at single dose for COVID-19 immunisation. The patient was vaccinated at hospital. No other vaccine was given within 4 weeks prior to the COVID vaccine. Medical history was none. The patient has no allergies to medications, food, or other products. The patient did not receive concomitant medications. On 30Dec2020 at 03:00 AM the patient experienced onset of severe right extremity pain, radiating down right arm, with rt arm weakness, numbness and tingling, after extensive workup determined to have brachial plexus neuritis / parsonage turner syndrome treated with steroids still recovering would not consider have had total recovery. The events were reported as non serious and resulted in doctor or other healthcare professional office/clinic visit. The patient was treated with steroids. The events were resolving. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, has been tested for COVID-19 (PCR Nasal Swab, negative on 24Jan2021).
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Paraesthesia, Sleep disorder
Clinical narrative: severe right extremity pain, radiating down right arm; with rt arm weakness, numbness and tingling; with rt arm weakness, numbness and tingling; with rt arm weakness, numbness and tingling; brachial plexus neuritis / parsonage turner syndrome; brachial plexus neuritis / parsonage turner syndrome; This is a spontaneous report from a contactable nurse (patient). A 40-year-old female patient (not pregnant) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number=EK5730), via an unspecified route of administration on 18Dec2020 09:30 at single dose for COVID-19 immunisation. The patient was vaccinated at hospital. No other vaccine was given within 4 weeks prior to the COVID vaccine. Medical history was none. The patient has no allergies to medications, food, or other products. The patient did not receive concomitant medications. On 30Dec2020 at 03:00 AM the patient experienced onset of severe right extremity pain, radiating down right arm, with rt arm weakness, numbness and tingling, after extensive workup determined to have brachial plexus neuritis / parsonage turner syndrome treated with steroids still recovering would not consider have had total recovery. The events were reported as non serious and resulted in doctor or other healthcare professional office/clinic visit. The patient was treated with steroids. The events were resolving. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, has been tested for COVID-19 (PCR Nasal Swab, negative on 24Jan2021).
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypoaesthesia, Muscular weakness, Neuralgic amyotrophy, Pain in extremity, Paraesthesia
Clinical narrative: severe right extremity pain, radiating down right arm; with rt arm weakness, numbness and tingling; with rt arm weakness, numbness and tingling; with rt arm weakness, numbness and tingling; brachial plexus neuritis / parsonage turner syndrome; brachial plexus neuritis / parsonage turner syndrome; This is a spontaneous report from a contactable nurse (patient). A 40-year-old female patient (not pregnant) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number=EK5730), via an unspecified route of administration on 18Dec2020 09:30 at single dose for COVID-19 immunisation. The patient was vaccinated at hospital. No other vaccine was given within 4 weeks prior to the COVID vaccine. Medical history was none. The patient has no allergies to medications, food, or other products. The patient did not receive concomitant medications. On 30Dec2020 at 03:00 AM the patient experienced onset of severe right extremity pain, radiating down right arm, with rt arm weakness, numbness and tingling, after extensive workup determined to have brachial plexus neuritis / parsonage turner syndrome treated with steroids still recovering would not consider have had total recovery. The events were reported as non serious and resulted in doctor or other healthcare professional office/clinic visit. The patient was treated with steroids. The events were resolving. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, has been tested for COVID-19 (PCR Nasal Swab, negative on 24Jan2021).
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: SARS-CoV-2 test
Clinical narrative: severe right extremity pain, radiating down right arm; with rt arm weakness, numbness and tingling; with rt arm weakness, numbness and tingling; with rt arm weakness, numbness and tingling; brachial plexus neuritis / parsonage turner syndrome; brachial plexus neuritis / parsonage turner syndrome; This is a spontaneous report from a contactable nurse (patient). A 40-year-old female patient (not pregnant) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number=EK5730), via an unspecified route of administration on 18Dec2020 09:30 at single dose for COVID-19 immunisation. The patient was vaccinated at hospital. No other vaccine was given within 4 weeks prior to the COVID vaccine. Medical history was none. The patient has no allergies to medications, food, or other products. The patient did not receive concomitant medications. On 30Dec2020 at 03:00 AM the patient experienced onset of severe right extremity pain, radiating down right arm, with rt arm weakness, numbness and tingling, after extensive workup determined to have brachial plexus neuritis / parsonage turner syndrome treated with steroids still recovering would not consider have had total recovery. The events were reported as non serious and resulted in doctor or other healthcare professional office/clinic visit. The patient was treated with steroids. The events were resolving. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, has been tested for COVID-19 (PCR Nasal Swab, negative on 24Jan2021).
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Body temperature increased, Headache, Loss of personal independence in daily activities, Lymphadenopathy, Pyrexia
Clinical narrative: lymph node soreness size of small orange/enlarged lymph node; Fever of 103.4/Day 3 still temp of 100; lymph node soreness size of small orange; This is a spontaneous report from a contactable nurse. A 55-year-old female patient received her second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EL0140) on her left arm, via an unspecified route of administration on 29Jan2021 09:30 at a single dose for covid-19 immunization. Medical history included asthma. Patient previously took codeine and experienced allergies. Historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) on 08Jan2021 (first dose). The patient experienced Fever of 103.4 lymph node soreness size of small orange on 30Jan2021 at 01:00AM. Day 3 still temp of 100 and enlarged lymph node. The patient also had a covid test on 24Jan2021 which tested negative.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Body temperature, Lymph node pain, Lymphadenopathy, Pyrexia, SARS-CoV-2 test
Clinical narrative: lymph node soreness size of small orange/enlarged lymph node; Fever of 103.4/Day 3 still temp of 100; lymph node soreness size of small orange; This is a spontaneous report from a contactable nurse. A 55-year-old female patient received her second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EL0140) on her left arm, via an unspecified route of administration on 29Jan2021 09:30 at a single dose for covid-19 immunization. Medical history included asthma. Patient previously took codeine and experienced allergies. Historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) on 08Jan2021 (first dose). The patient experienced Fever of 103.4 lymph node soreness size of small orange on 30Jan2021 at 01:00AM. Day 3 still temp of 100 and enlarged lymph node. The patient also had a covid test on 24Jan2021 which tested negative.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Fatigue, Headache, Malaise, Pain
Clinical narrative: Vomited once morning; feeling unwell/general feeling of not feeling well; low grade fever/102.4 temperature; chills; intense headache; whole body aches; This is a spontaneous report from a contactable nurse. A 50-year-old female patient (non-pregnant) received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3247, expiration date unknown), via an unspecified route of administration on left arm on 28Jan2021 at 10:45 at a single dose for COVID-19 immunisation at the doctor's office/ urgent care. Medical history included Complex post traumatic stress (cPTSD) and high blood pressure related to cPTSD. Allergies to medications, food, or other products was none. Concomitant medications included colecalciferol (VIT D3), duloxetine hydrochloride (CYMBALTA), losartan, buspirone and multi-vitamins. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EJ1685) on left arm on 06Jan2021 at 11:15 AM for COVID-19 immunization. On 28Jan2021, 22:30, patient began feeling unwell so orally checked temperature noting a low grade fever. Overnight and until morning on 30Jan2021. The patient also experience chills, 102.4 temperature, intense headache, whole body aches on 28Jan2021 at 22:30.. Vomited once morning of 29Jan2021. Began taking Tylenol at 8pm on 29Jan2021 until fever seemed to end midday on 30Jan2021, to get relief. On 31Jan2021 still experiencing headache, whole body aches and general feeling of not feeling well. Patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient had not been tested for COVID-19. No treatment received for the events not feeling well, chills, intense headache, whole body aches, and vomited once morning. The patient has not recovered from the events.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pyrexia
Clinical narrative: Vomited once morning; feeling unwell/general feeling of not feeling well; low grade fever/102.4 temperature; chills; intense headache; whole body aches; This is a spontaneous report from a contactable nurse. A 50-year-old female patient (non-pregnant) received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3247, expiration date unknown), via an unspecified route of administration on left arm on 28Jan2021 at 10:45 at a single dose for COVID-19 immunisation at the doctor's office/ urgent care. Medical history included Complex post traumatic stress (cPTSD) and high blood pressure related to cPTSD. Allergies to medications, food, or other products was none. Concomitant medications included colecalciferol (VIT D3), duloxetine hydrochloride (CYMBALTA), losartan, buspirone and multi-vitamins. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EJ1685) on left arm on 06Jan2021 at 11:15 AM for COVID-19 immunization. On 28Jan2021, 22:30, patient began feeling unwell so orally checked temperature noting a low grade fever. Overnight and until morning on 30Jan2021. The patient also experience chills, 102.4 temperature, intense headache, whole body aches on 28Jan2021 at 22:30.. Vomited once morning of 29Jan2021. Began taking Tylenol at 8pm on 29Jan2021 until fever seemed to end midday on 30Jan2021, to get relief. On 31Jan2021 still experiencing headache, whole body aches and general feeling of not feeling well. Patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient had not been tested for COVID-19. No treatment received for the events not feeling well, chills, intense headache, whole body aches, and vomited once morning. The patient has not recovered from the events.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Body temperature, Chills, Headache, Malaise, Pain
Clinical narrative: Vomited once morning; feeling unwell/general feeling of not feeling well; low grade fever/102.4 temperature; chills; intense headache; whole body aches; This is a spontaneous report from a contactable nurse. A 50-year-old female patient (non-pregnant) received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3247, expiration date unknown), via an unspecified route of administration on left arm on 28Jan2021 at 10:45 at a single dose for COVID-19 immunisation at the doctor's office/ urgent care. Medical history included Complex post traumatic stress (cPTSD) and high blood pressure related to cPTSD. Allergies to medications, food, or other products was none. Concomitant medications included colecalciferol (VIT D3), duloxetine hydrochloride (CYMBALTA), losartan, buspirone and multi-vitamins. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EJ1685) on left arm on 06Jan2021 at 11:15 AM for COVID-19 immunization. On 28Jan2021, 22:30, patient began feeling unwell so orally checked temperature noting a low grade fever. Overnight and until morning on 30Jan2021. The patient also experience chills, 102.4 temperature, intense headache, whole body aches on 28Jan2021 at 22:30.. Vomited once morning of 29Jan2021. Began taking Tylenol at 8pm on 29Jan2021 until fever seemed to end midday on 30Jan2021, to get relief. On 31Jan2021 still experiencing headache, whole body aches and general feeling of not feeling well. Patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient had not been tested for COVID-19. No treatment received for the events not feeling well, chills, intense headache, whole body aches, and vomited once morning. The patient has not recovered from the events.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pyrexia, Vomiting
Clinical narrative: Vomited once morning; feeling unwell/general feeling of not feeling well; low grade fever/102.4 temperature; chills; intense headache; whole body aches; This is a spontaneous report from a contactable nurse. A 50-year-old female patient (non-pregnant) received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3247, expiration date unknown), via an unspecified route of administration on left arm on 28Jan2021 at 10:45 at a single dose for COVID-19 immunisation at the doctor's office/ urgent care. Medical history included Complex post traumatic stress (cPTSD) and high blood pressure related to cPTSD. Allergies to medications, food, or other products was none. Concomitant medications included colecalciferol (VIT D3), duloxetine hydrochloride (CYMBALTA), losartan, buspirone and multi-vitamins. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EJ1685) on left arm on 06Jan2021 at 11:15 AM for COVID-19 immunization. On 28Jan2021, 22:30, patient began feeling unwell so orally checked temperature noting a low grade fever. Overnight and until morning on 30Jan2021. The patient also experience chills, 102.4 temperature, intense headache, whole body aches on 28Jan2021 at 22:30.. Vomited once morning of 29Jan2021. Began taking Tylenol at 8pm on 29Jan2021 until fever seemed to end midday on 30Jan2021, to get relief. On 31Jan2021 still experiencing headache, whole body aches and general feeling of not feeling well. Patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient had not been tested for COVID-19. No treatment received for the events not feeling well, chills, intense headache, whole body aches, and vomited once morning. The patient has not recovered from the events.
Age: 73.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pruritus, Urticaria
Clinical narrative: Hives on breasts, under breasts, chest, lower stomach, on back, under both arms; Hives/ a small one on injection site; This is a spontaneous report from a contactable consumer. A 73-year-old female patient received her first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EL9262) on her left arm, via an unspecified route of administration on 22Jan2021 14:30 at a single dose for covid-19 immunization. Medical history included arthritis, penicillin allergy, sulphas allergy and Celpholasporins allergy.  Concomitant medication included atorvastatin calcium (LIPITOR).  The patient previously took sporanox and nitrofurantoin and experienced allergies. It was reported that the patient experienced Hives on breasts, under breasts, chest, lower stomach, on back, under both arms, and a small one on injection site on 29Jan2021 at 10:00PM. The patient received Prednisone twice a day for 5 days as treatment for the events on the emergency room (visit). The outcome of the events was recovering.
Age: 73.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Urticaria, Vaccination site urticaria
Clinical narrative: Hives on breasts, under breasts, chest, lower stomach, on back, under both arms; Hives/ a small one on injection site; This is a spontaneous report from a contactable consumer. A 73-year-old female patient received her first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EL9262) on her left arm, via an unspecified route of administration on 22Jan2021 14:30 at a single dose for covid-19 immunization. Medical history included arthritis, penicillin allergy, sulphas allergy and Celpholasporins allergy.  Concomitant medication included atorvastatin calcium (LIPITOR).  The patient previously took sporanox and nitrofurantoin and experienced allergies. It was reported that the patient experienced Hives on breasts, under breasts, chest, lower stomach, on back, under both arms, and a small one on injection site on 29Jan2021 at 10:00PM. The patient received Prednisone twice a day for 5 days as treatment for the events on the emergency room (visit). The outcome of the events was recovering.
Age: 39.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Facial pain, Herpes zoster, Rash
Clinical narrative: excruciating pain on the left side my face; rash and swelling on the left side of my face; rash and swelling on the left side of my face; swelling of tongue; tingling in the face and tongue; tingling in the face and tongue; This is a spontaneous report from a contactable consumer (patient). A 39-year-old male patient received the first dose of bnt162b2 (BNT162B2, lot number: el3247, expiry date: not reported), via an unspecified route of administration on 18Jan2021 03:45 PM at a single dose on the left arm for COVID-19 immunization. The most recent COVID-19 vaccine was administered at a hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Medical history was none. The patient had no known allergies to medications, food, or other products. The patient had no concomitant medications. On 26Jan2021 06:00 AM, the patient experienced "excruciating pain on the left side my face and then noticed a rash and swelling on the left side of my face and swelling of tongue. Also tingling in the face and tongue." Therapeutic measures received as a result of adverse events included prescribed medication. Adverse events resulted into doctor or other healthcare professional office/clinic visit, emergency room/ department or urgent care. Outcome of the events was not recovered. The reporter assessed the events as non-serious. Since the vaccination, the patient has not been tested for COVID-19.
Age: 39.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Facial pain, Paraesthesia, Paraesthesia oral, Rash, Swelling face
Clinical narrative: excruciating pain on the left side my face; rash and swelling on the left side of my face; rash and swelling on the left side of my face; swelling of tongue; tingling in the face and tongue; tingling in the face and tongue; This is a spontaneous report from a contactable consumer (patient). A 39-year-old male patient received the first dose of bnt162b2 (BNT162B2, lot number: el3247, expiry date: not reported), via an unspecified route of administration on 18Jan2021 03:45 PM at a single dose on the left arm for COVID-19 immunization. The most recent COVID-19 vaccine was administered at a hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Medical history was none. The patient had no known allergies to medications, food, or other products. The patient had no concomitant medications. On 26Jan2021 06:00 AM, the patient experienced "excruciating pain on the left side my face and then noticed a rash and swelling on the left side of my face and swelling of tongue. Also tingling in the face and tongue." Therapeutic measures received as a result of adverse events included prescribed medication. Adverse events resulted into doctor or other healthcare professional office/clinic visit, emergency room/ department or urgent care. Outcome of the events was not recovered. The reporter assessed the events as non-serious. Since the vaccination, the patient has not been tested for COVID-19.
Age: 39.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Swollen tongue
Clinical narrative: excruciating pain on the left side my face; rash and swelling on the left side of my face; rash and swelling on the left side of my face; swelling of tongue; tingling in the face and tongue; tingling in the face and tongue; This is a spontaneous report from a contactable consumer (patient). A 39-year-old male patient received the first dose of bnt162b2 (BNT162B2, lot number: el3247, expiry date: not reported), via an unspecified route of administration on 18Jan2021 03:45 PM at a single dose on the left arm for COVID-19 immunization. The most recent COVID-19 vaccine was administered at a hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Medical history was none. The patient had no known allergies to medications, food, or other products. The patient had no concomitant medications. On 26Jan2021 06:00 AM, the patient experienced "excruciating pain on the left side my face and then noticed a rash and swelling on the left side of my face and swelling of tongue. Also tingling in the face and tongue." Therapeutic measures received as a result of adverse events included prescribed medication. Adverse events resulted into doctor or other healthcare professional office/clinic visit, emergency room/ department or urgent care. Outcome of the events was not recovered. The reporter assessed the events as non-serious. Since the vaccination, the patient has not been tested for COVID-19.
Age: 39.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Adverse reaction, Erythema, Facial pain, Herpes zoster, Insomnia
Clinical narrative: excruciating pain on the left side my face; rash and swelling on the left side of my face; rash and swelling on the left side of my face; swelling of tongue; tingling in the face and tongue; tingling in the face and tongue; This is a spontaneous report from a contactable consumer (patient). A 39-year-old male patient received the first dose of bnt162b2 (BNT162B2, lot number: el3247, expiry date: not reported), via an unspecified route of administration on 18Jan2021 03:45 PM at a single dose on the left arm for COVID-19 immunization. The most recent COVID-19 vaccine was administered at a hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Medical history was none. The patient had no known allergies to medications, food, or other products. The patient had no concomitant medications. On 26Jan2021 06:00 AM, the patient experienced "excruciating pain on the left side my face and then noticed a rash and swelling on the left side of my face and swelling of tongue. Also tingling in the face and tongue." Therapeutic measures received as a result of adverse events included prescribed medication. Adverse events resulted into doctor or other healthcare professional office/clinic visit, emergency room/ department or urgent care. Outcome of the events was not recovered. The reporter assessed the events as non-serious. Since the vaccination, the patient has not been tested for COVID-19.
Age: 39.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Mass, Rash, Swelling face
Clinical narrative: excruciating pain on the left side my face; rash and swelling on the left side of my face; rash and swelling on the left side of my face; swelling of tongue; tingling in the face and tongue; tingling in the face and tongue; This is a spontaneous report from a contactable consumer (patient). A 39-year-old male patient received the first dose of bnt162b2 (BNT162B2, lot number: el3247, expiry date: not reported), via an unspecified route of administration on 18Jan2021 03:45 PM at a single dose on the left arm for COVID-19 immunization. The most recent COVID-19 vaccine was administered at a hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Medical history was none. The patient had no known allergies to medications, food, or other products. The patient had no concomitant medications. On 26Jan2021 06:00 AM, the patient experienced "excruciating pain on the left side my face and then noticed a rash and swelling on the left side of my face and swelling of tongue. Also tingling in the face and tongue." Therapeutic measures received as a result of adverse events included prescribed medication. Adverse events resulted into doctor or other healthcare professional office/clinic visit, emergency room/ department or urgent care. Outcome of the events was not recovered. The reporter assessed the events as non-serious. Since the vaccination, the patient has not been tested for COVID-19.
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest pain, Dizziness, Headache, Urticaria, Vision blurred
Clinical narrative: Burning at site.. immediately   feeling lightheaded, heavy chest pains within 3 minutes and maintained for two hours Rapid rise in Blood Pressure within 5 minutes of injection staying at over 180/109 for two hours Hives 90 minutes after injection Sharp pain in facial nerves, neck lasting days
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood pressure increased, Chest pain, Dizziness, Facial pain, Injection site pain
Clinical narrative: Burning at site.. immediately   feeling lightheaded, heavy chest pains within 3 minutes and maintained for two hours Rapid rise in Blood Pressure within 5 minutes of injection staying at over 180/109 for two hours Hives 90 minutes after injection Sharp pain in facial nerves, neck lasting days
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Neck pain, Urticaria
Clinical narrative: Burning at site.. immediately   feeling lightheaded, heavy chest pains within 3 minutes and maintained for two hours Rapid rise in Blood Pressure within 5 minutes of injection staying at over 180/109 for two hours Hives 90 minutes after injection Sharp pain in facial nerves, neck lasting days
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pharyngeal swelling, Sensation of foreign body
Clinical narrative: trouble sleeping; lump in her throat; high blood pressures; feeling very shaky and very weak; feeling very shaky and very weak; feeling unwell; alternating slow heartbeat and fast heartbeat; a weird feeling in her head like pressure but not a headache/pressure feeling in my head; they are going to check me for all the ingredients in the Pfizer vaccine that could give me an allergic reaction.; This is a spontaneous report from a contactable consumer.   A 65 years old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) on 31Jan2021 at single dose via an unspecified route of administration  for COVID-19 immunization. Relevant medical history included allergic to shrimp, lupus anticoagulant syndrome, chronic kidney disease and antiphospholipid syndrome. Concomitant medications included amlodipine, HCTZ, losartan, acetylsalicylic acid (ASPIRIN (E.C.) and atorvastatin calcium (LIPITOR ORIFARM). The patient informed that immediately after receiving the injection she felt a lump in her throat and could not swallow, still present now. Patient also informed that after vaccination she was having a very high blood pressures, feeling very shaky and very weak, a weird feeling in her head like pressure but not a headache, trouble sleeping because of the pressure feeling in my head, feeling unwell and alternating slow heartbeat and fast heartbeat.  Patient also reported she had scheduled an allergist appointment and they are going to check me for all the ingredients in the Pfizer vaccine that could give me an allergic reaction. At the time of the reporting event outcome was unknown.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Heart rate irregular, Hypersensitivity, Hypertension, Malaise
Clinical narrative: trouble sleeping; lump in her throat; high blood pressures; feeling very shaky and very weak; feeling very shaky and very weak; feeling unwell; alternating slow heartbeat and fast heartbeat; a weird feeling in her head like pressure but not a headache/pressure feeling in my head; they are going to check me for all the ingredients in the Pfizer vaccine that could give me an allergic reaction.; This is a spontaneous report from a contactable consumer.   A 65 years old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) on 31Jan2021 at single dose via an unspecified route of administration  for COVID-19 immunization. Relevant medical history included allergic to shrimp, lupus anticoagulant syndrome, chronic kidney disease and antiphospholipid syndrome. Concomitant medications included amlodipine, HCTZ, losartan, acetylsalicylic acid (ASPIRIN (E.C.) and atorvastatin calcium (LIPITOR ORIFARM). The patient informed that immediately after receiving the injection she felt a lump in her throat and could not swallow, still present now. Patient also informed that after vaccination she was having a very high blood pressures, feeling very shaky and very weak, a weird feeling in her head like pressure but not a headache, trouble sleeping because of the pressure feeling in my head, feeling unwell and alternating slow heartbeat and fast heartbeat.  Patient also reported she had scheduled an allergist appointment and they are going to check me for all the ingredients in the Pfizer vaccine that could give me an allergic reaction. At the time of the reporting event outcome was unknown.